HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
4 hedge funds and large institutions have $2.75M invested in Hepion Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.39M |
| 2 |
Morgan Stanley
New York
|
-$172K |
| 3 |
JPMorgan Chase & Co
New York
|
-$116K |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$99K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$87K |
